Odyssey Therapeutics(ODTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ODTX Odyssey Therapeutics

交易中 09-01 15:19:26 EDT

24.67

+0.15

+0.61%

最高25.03	最低24.06	成交量10.37万
今开24.21	昨收24.52	日振幅3.96%
总市值11.85亿	流通市值3.27亿	总股本4,803万
成交额254.30万	换手率0.78%	流通股本1,324万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ODTX","market":"US","secType":"STK","nameCN":"Odyssey Therapeutics","latestPrice":24.67,"timestamp":1788290361050,"preClose":24.52,"halted":0,"volume":103728,"delay":0,"changeRate":0.0061174551386624035,"floatShares":13240000,"shares":48031300,"eps":-3.341,"marketStatus":"交易中","change":0.15,"latestTime":"09-01 15:19:26 EDT","open":24.21,"high":25.03,"low":24.06,"amount":2542976.97696,"amplitude":0.03956,"askPrice":24.87,"askSize":17,"bidPrice":24.62,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-3.341,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1788292800000},"marketStatusCode":2,"adr":0,"listingDate":1778212800000,"exchange":"NASDAQ","adjPreClose":24.52,"postHourTrading":{"tag":"盘后","latestPrice":24.52,"preClose":24.52,"latestTime":"19:30 EDT","volume":1868,"amount":45803.36,"timestamp":1788219003282,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.697562},"requestUrl":"/m/hq/s/ODTX/tweets","defaultTab":"tweets","newsList":[{"id":"1117139045","title":"Odyssey Therapeutics获H.C. Wainwright首予买入评级，目标价定为44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117139045","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117139045?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:13","pubTimestamp":1787825595,"startTime":"0","endTime":"0","summary":"Odyssey Therapeutics公司今日迎来重要机构关注——H.C. Wainwright正式启动对该公司的覆盖研究，并给予“买入”评级。与此同时，该机构设定其目标价格为每股44美元。这一举动不仅彰显了市场对Odyssey Therapeutics发展潜力的认可，也为投资者提供了新的参考依据。作为一家备受瞩目的生物医药企业，Odyssey Therapeutics此番获得积极评价，或将在资本市场引发新一轮关注热潮。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ODTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634465519","title":"美股异动 | Odyssey Therapeutics(ODTX.US)登陆美股市场 开盘股价波动不大","url":"https://stock-news.laohu8.com/highlight/detail?id=2634465519","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2634465519?lang=zh_cn&edition=full","pubTime":"2026-05-09 00:00","pubTimestamp":1778256000,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，Odyssey Therapeutics(ODTX.US)登陆美股市场，开盘股价波动不大，IPO价格为18美元。截至发稿，该股跌超1%，报17.81美元。Odyssey Therapeutics是一家总部位于美国波士顿的临床阶段生物科技公司，主要专注于自身免疫性及炎症性疾病药物研发。公司核心产品为OD-001，这是一款用于治疗溃疡性结肠炎的小分子药物，目前已进入中期临床试验阶段。此外，公司还布局红斑狼疮、特应性皮炎等多个免疫疾病管线。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439831.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","ODTX","BK4539","LENZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://odysseytx.com","stockEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":0.2953},{"period":"3month","weight":0.4483},{"period":"6month","weight":0.3622},{"period":"ytd","weight":0.3622}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0268},{"period":"3month","weight":0.0098},{"period":"6month","weight":0.1196},{"period":"1year","weight":0.1891},{"period":"ytd","weight":0.1248}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Odyssey Therapeutics, Inc.于2021年4月在特拉华州注册成立。Odyssey是一家临床阶段的生物制药公司，由一个寻求改变自身免疫性和炎症性疾病患者护理标准的药物猎手团队和董事会领导。为了实现这一目标，该公司正在开发旨在精确针对疾病病理的药物，最初的重点是先天免疫系统。该公司相信，他们对免疫生物学的深刻理解，加上在药物、计算和蛋白质化学、结构生物学、遗传学和药理学方面的领先专业知识，使他们能够识别和药物驱动疾病的关键信号节点。","exchange":"NASDAQ","name":"Odyssey Therapeutics","nameEN":"Odyssey Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Odyssey Therapeutics(ODTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Odyssey Therapeutics(ODTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Odyssey Therapeutics,ODTX,Odyssey Therapeutics股票,Odyssey Therapeutics股票老虎,Odyssey Therapeutics股票老虎国际,Odyssey Therapeutics行情,Odyssey Therapeutics股票行情,Odyssey Therapeutics股价,Odyssey Therapeutics股市,Odyssey Therapeutics股票价格,Odyssey Therapeutics股票交易,Odyssey Therapeutics股票购买,Odyssey Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Odyssey Therapeutics(ODTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Odyssey Therapeutics(ODTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}